MX9706182A - Uso de acido hialuronico para el tratamiento de cistitis intersticial. - Google Patents

Uso de acido hialuronico para el tratamiento de cistitis intersticial.

Info

Publication number
MX9706182A
MX9706182A MX9706182A MX9706182A MX9706182A MX 9706182 A MX9706182 A MX 9706182A MX 9706182 A MX9706182 A MX 9706182A MX 9706182 A MX9706182 A MX 9706182A MX 9706182 A MX9706182 A MX 9706182A
Authority
MX
Mexico
Prior art keywords
interstitial cystitis
hyaluronic acid
treatment
cystitis
daltons
Prior art date
Application number
MX9706182A
Other languages
English (en)
Other versions
MXPA97006182A (es
Inventor
Alvaro Morales
Stanley J Alkemade
Original Assignee
Bioniche Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/388,038 external-priority patent/US5591724A/en
Application filed by Bioniche Inc filed Critical Bioniche Inc
Publication of MX9706182A publication Critical patent/MX9706182A/es
Publication of MXPA97006182A publication Critical patent/MXPA97006182A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)

Abstract

Un método de tratamiento que comprende poner en contacto a la vejiga interna y a las estructuras asociadas en un mamífero que tiene cistitis intersticial, con una solucion que contiene ácido hialuronico que tiene un peso molecular promedio no menor a 2 x 10-6 Daltons en una concentracion efectiva para tratar la cistitis intersticial.
MXPA/A/1997/006182A 1995-02-14 1997-08-13 Uso de acido hialuronico para el tratamiento de cistitis intersticial MXPA97006182A (es)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US08/388,038 US5591724A (en) 1995-02-14 1995-02-14 Method for treating the urinary bladder and associated structures using hyaluronic acid
US08388038 1995-02-14
US59101596A 1996-02-08 1996-02-08
US591015 1996-02-08
US591,015 1996-02-08

Publications (2)

Publication Number Publication Date
MX9706182A true MX9706182A (es) 1998-07-31
MXPA97006182A MXPA97006182A (es) 1998-11-09

Family

ID=

Also Published As

Publication number Publication date
TR199700782T1 (xx) 1998-03-21
NO315842B1 (no) 2003-11-03
AU4617996A (en) 1996-09-04
CN1181016A (zh) 1998-05-06
IN181358B (es) 1998-05-30
PT813417E (pt) 2003-12-31
JP4354528B2 (ja) 2009-10-28
HUP9800467A2 (hu) 1998-06-29
WO1996025168A1 (en) 1996-08-22
HUP9800467A3 (en) 1999-01-28
CZ288218B6 (en) 2001-05-16
BR9607601A (pt) 1999-09-14
CA2203621C (en) 1998-04-28
KR19980702251A (ko) 1998-07-15
CA2203621A1 (en) 1996-08-22
DE69629553T2 (de) 2004-06-17
NO973732D0 (no) 1997-08-13
EP0813417A1 (en) 1997-12-29
US5888986A (en) 1999-03-30
NO973732L (no) 1997-10-10
DE69629553D1 (de) 2003-09-25
ATE247476T1 (de) 2003-09-15
DK0813417T3 (da) 2003-11-03
NZ300903A (en) 1999-07-29
CZ257497A3 (cs) 1998-01-14
AU705289B2 (en) 1999-05-20
EP0813417B1 (en) 2003-08-20
KR100268660B1 (ko) 2000-10-16
JPH10513476A (ja) 1998-12-22
ES2205013T3 (es) 2004-05-01

Similar Documents

Publication Publication Date Title
NZ300903A (en) Use of hyaluronic acid having an mr of not less than 20000 daltons for the treatment of cystitis
EP0802782A4 (en) PROPHYLACTIC AND THERAPEUTIC TREATMENT OF MAIN SENSITIZATION AND IRRITATION
ZA988278B (en) Ionic polymers as toxin-binding agents
WO1995017154A3 (en) Use of thalidomide for treating neurocognitive disorders
UA32429C2 (uk) Засіб для лікування нетримання сечі
CA2194976A1 (en) Wound healing agent
PL338705A1 (en) Application of gaba analogues in preventing and treating gastrointestinal diseases
IL134669A0 (en) Butyrate derivatives in the treatment of fibromyalgia and chronic fatigue syndrome
PT646012E (pt) Cura de feridas e tratamento de perturbacoes fibroticas por tgfbeta-3
BR9912599A (pt) Agentes colinérgicos no tratamento da presbiopia
BR8907770A (pt) Solucao para tratamento de metal,solucao aquosa e processo para tratar uma superficie de metal
EP0358386A3 (en) Method for the treatment of wool
GR3022030T3 (en) Composition for treating mastitis and metritis
PL328959A1 (en) Method of treating or preventing interstitial cystitis
NZ512086A (en) Method of increasing fat firmness and improving meat quality in animals
DE69725897D1 (de) Behandlung von störungen mittels interleukin-9
AU1329895A (en) Metallic implant and process for treating a metallic implant
AU7207798A (en) A surface-treatment plant
ATE225181T1 (de) Verwendung von heparinen niedrigeren molekulargewichtes zur behandlung von hirnödemen
CS275038B2 (en) Method of sewage waters treatment with content of ethylenediaminetetraacetic acid and their above all calcerous complexes
AU642173B2 (en) Improvements in or relating to a treatment and or a method of treating
UA6506A (uk) Спосіб прогнозування ефективності імунодепресивної терапії у дітей з нефротичною формою гломерулонефриту
MX9700626A (es) USO DE AZASPIRANOS EN LA REPARACIaN DE COMPOSICIONES PARA TRATAR INFECCIONES OPORTUNISTAS.
UA28207A (uk) Спосіб лікування черепно-мозкової травми
DE69715898D1 (de) Verwendung von hyaluronidase